Soretolide is an orally active benzamide derivative with anticonvulsant effects and a similar profile of activity to carbamazepine. In animal models, soretolide showed an anticonvulsant profile similar to carbamazepine, being active in the maximal electroshock test and poorly active against pentylenetetrazole-induced seizures. Researchers at the University of Washington, USA and Laboratoires Biocodex, France were investigating the potential use of soretolide as an anticonvulsant. However, development of the compound appears to have been discontinued.